Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study

Jingu, Keiichi; Matsushita, Haruo; Takeda, Ken; Umezawa, Rei; Takahashi, Chiaki; Sugawara, Toshiyuki; Kubozono, Masaki; Abe, Keiko; Tanabe, Takaya; Shirata, Yuko; Yamamoto, Takaya; Ishikawa, Youjirou; Nemoto, Kenji

doi:10.1186/1471-2407-12-542

Table 1 Patients’ characteristics

From: Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study

patient number	age	gender	preoperative stage (UICC*1997)	time interval between surgery and recurrence (months)	PS (ECOG†)	recurrent regions	field	number of cycles of chemo	tumor response (RECIST*)	irradiated field recurrence (yes/no)	recurrence (yes/no)	dead/alive	survival period (months)
1	70	male	IIA	6	1	subclavicular/mediastinal	T-shaped	2	PR	yes	yes	dead	6.5
2	64	male	III	6	1	mediastinal	T-shaped	2	SD	yes	yes	dead	14
3	64	male	IIA	47	1	anastomosis/subclavicular/mediastinal	T-shaped	2	SD	no	yes	dead	5
4	50	male	III	12	1	abdominal	local	2	PR	no	yes	dead	8
5	64	male	III	7	1	mediastinal/abdominal	local	1	SD	no	yes	dead	5
6	62	male	III	13	2	anastomosis	T-shaped	2	PR	no	yes	dead	4
7	55	male	III	5	3	anastomosis/subclavicular/abdominal	local	2	PR	no	yes	dead	5.5
8	61	female	IIB	28	0	mediastinal	T-shaped	2	C R	no	no	alive	54
9	64	male	III	8	0	anastomosis/mediastinal	T-shaped	2	C R	yes	yes	dead	23.5
10	62	male	IIB	22	1	abdominal	local	2	PR	no	yes	dead	10
11	65	male	I	102	0	mediastinal	T-shaped	2	C R	no	no	alive	90
12	60	male	IV B	6	1	subclavicular	local	2	PR	no	no	alive	98
13	72	male	III	7	0	abdominal	local	2	PR	no	yes	dead	39
14	67	male	III	46	0	subclavicular	T-shaped	2	C R	no	no	alive	49.5
15	54	male	n.a.	4	0	abdominal	local	2	SD	no	yes	dead	12
16	68	male	III	19	1	anastomosis/subclavicular	local	2	PR	no	yes	dead	33
17	69	male	III	6	1	anastomosis/subclavicular	local	2	PR	no	yes	dead	28.5
18	68	male	n.a.	36	2	mediastinal	local	2	PR	no	no	dead	18.5
19	62	male	III	10	1	mediastinal	local	2	PR	no	no	alive	16.5
20	66	male	IV B	66	0	subclavicular	local	1	PR	yes	yes	dead	116
21	57	male	III	11	3	anastomosis	T-shaped	2	PR	no	no	dead	8
22	52	male	III	23	1	mediastinal	T-shaped	1	PD	no	yes	dead	6
23	56	male	I	54	1	anastomosis	local	1	PR	no	no	dead	6
24	62	male	IIB	23	0	mediastinal	local	2	PR	no	no	alive	125.5
25	71	male	I	4	1	subclavicular	local	2	SD	no	no	alive	107
26	61	male	I	83	1	abdominal	local	2	SD	yes	yes	dead	42
27	72	male	III	16	0	mediastinal	local	1	SD	no	no	alive	29
28	71	male	III	6	2	anastomosis	T-shaped	2	C R	yes	yes	dead	13.5
29	63	male	III	39	0	mediastinal	local	2	PR	no	yes	dead	45
30	72	male	III	4	1	mediastinal	local	2	PR	no	yes	dead	21

* UICC: Union for International Cancer Control.
† ECOG: Eastern Cooperative Oncology Group.
# RECIST: Response Evaluation Criteria in Solid Tumors.

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us